Salud

BCIE prestará $50 millones a Costa Rica para comprar vacuna de covid-19

Entidad financiera mantiene conversaciones 'avanzadas' con la OPS para definir el pago que se efectuará con el fin de reservar los lotes del inmunizador

(FILES) In this file photo Dr. Nita Patel, Director of Antibody discovery and Vaccine development, lifts a vial with a potential coronavirus, COVID-19, vaccine at Novavax labs in Gaithersburg, Maryland on March 20, 2020, one of the labs developing a vaccine for the coronavirus, COVID-19. - The US on July 7, 2020 announced it was providing $1.6 billion in funding for the development and manufacture of a COVID-19 vaccine candidate produced by biotech firm Novavax, the largest amount awarded under Operation Warp Speed. Separately, the US also said it was providing $450 million to Regeneron for its experimental COVID-19 treatment and prophylaxis, a combination of two antibodies. (Photo by ANDREW CABALLERO-REYNOLDS / AFP)
(FILES) In this file photo Dr. Nita Patel, Director of Antibody discovery and Vaccine development, lifts a vial with a potential coronavirus, COVID-19, vaccine at Novavax labs in Gaithersburg, Maryland on March 20, 2020, one of the labs developing a vaccine for the coronavirus, COVID-19. - The US on July 7, 2020 announced it was providing $1.6 billion in funding for the development and manufacture of a COVID-19 vaccine candidate produced by biotech firm Novavax, the largest amount awarded under Operation Warp Speed. Separately, the US also said it was providing $450 million to Regeneron for its experimental COVID-19 treatment and prophylaxis, a combination of two antibodies. (Photo by ANDREW CABALLERO-REYNOLDS / AFP) ANDREW CABALLERO-REYNOLDS
Hay cerca de 150 vacunas contra la covid-19 en distintas fases de desarrollo en todo el mundo, ocho de ellas están en su etapa final de ensayos clínicos. Foto: AFP (ANDREW CABALLERO-REYNOLDS/AFP)

El Banco Centroamericano de Integración Económica (BCIE) le concederá un préstamo de $50 millones a Costa Rica para adquirir la vacuna contra la covid-19, la cual se encuentra en fase de desarrollo.

El presidente ejecutivo de la entidad financiera, Dante Mossi, confirmó a La Nación que sostienen negociaciones con la Organización Panamericana de la Salud (OPS) con el propósito de definir el pago que se efectuará para reservar los lotes del inmunizador.

‌
‌

‌

‌
‌

‌

‌